Abstract
Objective Alterations in cerebral blood flow (CBF) and cerebral oxygenation are implicated in altitude-associated diseases. We assessed the dynamic changes in CBF and peripheral and cerebral oxygenation engendered by ascent to altitude with partial acclimatization and hyperventilation using a combination of near-infrared spectroscopy, transcranial Doppler ultrasound, and diffuse correlation spectroscopy. Methods Peripheral (Spo2) and cerebral (Scto2) oxygenation, end-tidal carbon dioxide (ETCO2), and cerebral hemodynamics were studied in 12 subjects using transcranial Doppler and diffuse correlation spectroscopy (DCS) at 75 m and then 2 days and 7 days after ascending to 4559 m above sea level. After obtaining baseline measurements, subjects hyperventilated to reduce baseline ETCO2 by 50%, and a further set of measurements were obtained. Results Cerebral oxygenation and peripheral oxygenation showed a divergent response, with cerebral oxygenation decreasing at day 2 and decreasing further at day 7 at altitude, whereas peripheral oxygenation decreased on day 2 before partially rebounding on day 7. Cerebral oxygenation decreased after hyperventilation at sea level (Scto2 from 68.8% to 63.5%; P <.001), increased after hyperventilation after 2 days at altitude (Scto2 from 65.6% to 69.9%; P =.001), and did not change after hyperventilation after 7 days at altitude (Scto2 from 62.2% to 63.3%; P =.35). Conclusions An intensification of the normal cerebral hypocapnic vasoconstrictive response occurred after partial acclimatization in the setting of divergent peripheral and cerebral oxygenation. This may help explain why hyperventilation fails to improve cerebral oxygenation after partial acclimatization as it does after initial ascent. The use of DCS is feasible at altitude and provides a direct measure of CBF indices with high temporal resolution.
Original language | English |
---|---|
Article number | 553 |
Pages (from-to) | 133-141 |
Number of pages | 9 |
Journal | Wilderness and Environmental Medicine |
Volume | 26 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Jun 2015 |
Bibliographical note
Funding Information:Unrestricted grant support was provided by Deltex Medical and Smiths Medical. Mike Grocott leads the Xtreme-Everest oxygen research consortium which has received unrestricted grant funding from BOC Medical (Linde Group), Ely-Lilly Critical Care, Smiths Medical, Deltex Medical, London Clinic, and Rolex. All funds were paid directly to the home institutions of researchers within the consortium. Mike Grocott has also received honoraria for speaking (not related to this review) and/or travel expenses from Baxter, Fresenius-Kabi, BOC Medical (Linde Group), and Ely-Lilly Critical Care.
Funding Information:
Funding for this project came from The Wilderness Medical Society Hultgren Grant and American Alpine Club Research Grants to Dr Sanborn and for biostatistical support through NICHD P30 HD026979 .
Publisher Copyright:
© 2015 Wilderness Medical Society.
Keywords
- altitude
- cerebral oxygenation
- Key words hypoxia
ASJC Scopus subject areas
- Emergency Medicine
- Public Health, Environmental and Occupational Health